Production of ultrafine sumatriptan succinate particles for pulmonary delivery
- PMID: 18581210
- DOI: 10.1007/s11095-008-9586-3
Production of ultrafine sumatriptan succinate particles for pulmonary delivery
Abstract
Purpose: Drug particle physical properties are critical for the efficiency of a drug delivered to the lung. The purpose of this study was to produce ultrafine sumatriptan succinate particles for inhalation.
Methods: Sumatriptan succinate particles were produced via reactive precipitation without any surfactants. Several low toxic organic solvents such as acetone, isopropanol, and tetrahydrofuran were investigated as the reaction medium. And the dry powder was obtained via spray drying. FT-IR, HPLC, SEM and XRD were exploited to characterize the physicochemical properties of the ultrafine sumatriptan succinate dry powder. The aerosol performance of the powder was evaluated using an Aeroliser connected to a multi stage liquid impinger operating at 60 l/min.
Results: The mean particle size of the ultrafine sumatriptan succinate particles obtained under optimum conditions was in the range of 630-679 nm and consequently they were in the respirable range. The spray-dried powder whose fine particle fraction was increased up to 50.6 +/- 8.2% showed good aerosol performance whereas the vacuum-dried powder was approximate 18.2 +/- 3.0%.
Conclusions: Good aerosol performance ultrafine sumatriptan succinate particles could be produced by reactive precipitation without any additives followed by spray drying at the optimum parameters.
Similar articles
-
Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):81-93. doi: 10.1089/jamp.2013.1078. Epub 2014 Feb 6. J Aerosol Med Pulm Drug Deliv. 2014. PMID: 24502451 Free PMC article.
-
High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies.AAPS PharmSciTech. 2014 Dec;15(6):1574-87. doi: 10.1208/s12249-014-0182-z. Epub 2014 Aug 20. AAPS PharmSciTech. 2014. PMID: 25139763 Free PMC article.
-
Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.Int J Nanomedicine. 2013;8:275-93. doi: 10.2147/IJN.S30724. Epub 2013 Jan 15. Int J Nanomedicine. 2013. PMID: 23355776 Free PMC article.
-
The role of particle properties in pharmaceutical powder inhalation formulations.J Aerosol Med. 2002 Fall;15(3):325-30. doi: 10.1089/089426802760292672. J Aerosol Med. 2002. PMID: 12396421 Review.
-
Dry powder aerosol delivery systems: current and future research directions.J Aerosol Med. 2006 Spring;19(1):21-7. doi: 10.1089/jam.2006.19.21. J Aerosol Med. 2006. PMID: 16551211 Review.
Cited by
-
Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization.Mol Pharm. 2010 Aug 2;7(4):1274-82. doi: 10.1021/mp1000718. Mol Pharm. 2010. PMID: 20575527 Free PMC article.
-
Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design.AAPS PharmSciTech. 2015 Feb;16(1):118-28. doi: 10.1208/s12249-014-0211-y. Epub 2014 Sep 11. AAPS PharmSciTech. 2015. PMID: 25209687 Free PMC article.
-
Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent.Int J Pharm. 2010 May 31;391(1-2):305-12. doi: 10.1016/j.ijpharm.2010.03.009. Epub 2010 Mar 7. Int J Pharm. 2010. PMID: 20214960 Free PMC article.
-
Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration.Pharm Res. 2009 Jul;26(7):1752-63. doi: 10.1007/s11095-009-9886-2. Epub 2009 May 5. Pharm Res. 2009. PMID: 19415471 Free PMC article.
-
Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols.Eur J Pharm Sci. 2011 Nov 20;44(4):522-33. doi: 10.1016/j.ejps.2011.09.014. Epub 2011 Sep 21. Eur J Pharm Sci. 2011. PMID: 21964203 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources